Breaking the Gene Therapy Barrier for Life-Threatening Red Blood Cell Disorders

Summary

GlobalData’s report, “Breaking the Gene Therapy Barrier for Life-Threatening Red Blood Cell Disorders” takes a look at gene therapy for the treatment of blood disorders such as beta-thalassemia and sickle cell anemia. An international team of researchers led by scientists at Weill-Cornell Medical College in New York City have designed a novel gene therapy strategy with potentially curative implications for patients with beta-thalassemia and sickle cell anemia. This development represents an important advance in addressing significant unmet market needs regarding the future development of therapeutic products for these two serious red blood cell disorders.

Scope

- Introduction and detail on two red blood cell disorders – sickle cell anemia and beta-thalassemia
- Current gene therapy initiatives for beta-thalassemia and sickle cell anemia
- Challenges to Gene Therapy
- Market Implications

Reasons to buy

- Understand the effectiveness of gene therapy in the treatment of red blood cell disorders
- Get the most up to date gene therapy-based research being carried out for sickle cell anemia and beta-thalassemia

Table Of Contents

1 Table of Contents
1 Table of Contents 1
2 Summary 1
3 Breaking the Gene Therapy Barrier for Life-Threatening Red Blood Cell Disorders 1
3.1 Characteristics of Beta-Thalassemia and Sickle Cell Anemia 1
3.2 Novel Gene Therapy for Beta-Thalassemia and Sickle Cell Anemia 2
3.3 Overcoming Barriers to Gene Therapy 2
3.4 Market Implications 2
4 Appendix 3
4.1 Methodology 3
4.1.1 Coverage 3
4.1.2 Secondary Research 3
4.1.3 Primary Research 3
4.1.4 Expert Panel Validation 4
4.2 Contact Us 4
4.3 Disclaimer 4

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

3D Bioprinting 2014-2024: Applications, Markets, Players

3D Bioprinting 2014-2024: Applications, Markets, Players

  • $ 3 995
  • Industry report
  • April 2014
  • by IDTechEx Ltd

3D bioprinting constitutes a raft of technologies, commercial and not-yet commercial, which have the potential to significantly impact a number of major markets, including in vitro testing for more efficient ...

Plasma Etching: Market Analysis and Strategic Issues

Plasma Etching: Market Analysis and Strategic Issues

  • $ 2 495
  • Industry report
  • July 2014
  • by Information Network

The future needs in plasma etching will be for ever tighter control of process variability, higher selectivity and less damage. This report addresses the strategic issues impacting both the user and supplie ...

Kidney Transplantation - Pipeline Review, H1 2014

Kidney Transplantation - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • March 2014
  • by Global Markets Direct

Kidney Transplantation - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Kidney Transplantation - Pipeline Review, H1 2014', provides an overview of the Kidney Transplantation's therapeutic ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.